SCNI

Conviction 0HealthcareScan · Thu, Jun 25, 2026

SCNI$0.2610-4.11%

ResistanceSupportVol 14

Vol MA14 666.68K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Scinai Immunotherapeutics Ltd.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.scinai.com ↗

Price0.2610

Change-4.11%

Gap-4.00%

Rel volume0.37×

Avg volume539.8K

Avg $ vol196.78K

SMA 200.3704

SMA 500.4874

SMA 2000.8763

Price vs 50-46.45%

Price vs 200-70.22%

MA stackbearish

50/200 cross—

Supertrenddown · 0.4008

RSI (14)27

MACD hist-0.00

MACD cross—

Stoch %K / %D0 / 4

ADX (14)24

+DI / −DI14 / 29

RSI divergence—

MACD divergence—

ATR %+19.18%

ADR %11.76%

52w high2.52

52w low0.2610

From 52w high-89.64%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width76.63%

%B0.11

Donchian pos0.00%

Donchian high0.5000

Donchian low0.2610

AVWAP (52w high)1.14

vs AVWAP high-77.11%

AVWAP (52w low)0.2640

vs AVWAP low-1.15%

OBV trendFlat

Chaikin MF (20)0.06

Today vs 20d0.37×

Avg vol (14d)666.68K

Avg vol (20d)539.8K

Avg $ vol (20d)196.78K

Market cap3.62B

RS 3m (vs SPY)-71.85%

RS 6m (vs SPY)-73.28%

RS line new highNo

Trend template0/8

Technical rank2.4

1 week-22.55%

1 month-45.96%

3 months-61.04%

6 months-67.19%

1 year-88.99%

YTD-64.22%

P/E-624.71

P/B-752.77

P/S—

P/FCF-446.96

EPS-0.0100

Div yield—

ROE120.50%

ROA-24.88%

Debt/Eq-0.08

Current4.28

EV/EBITDA-343.88

Gross margin—

Net margin—

Rev growth—

EPS growth29.37%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value3.61B

Revenue—

Net income-3.52M

Gross profit—

Free cash flow-8.1M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out3.96M

Employees45

ListedTue, May 12, 2015

Free float63.98M

Float %0.5%

Short interest97.74K

Days to cover0.4d

Short volume33.3%

Squeeze score2 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank2.4 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.5399

Support0.3536

Days since event—

Candle confirm—

News sentiment—

Financials as of Fri, Mar 31, 2023 · quarterly.

Congress activity

Disclosed STOCK Act trades in SCNI

All disclosures →

No recent disclosed trades by Congress in SCNI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SCNI · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Reichman Amir Chief Executive Officer · Ordinary Shares · 2026-06-16	Grant	400M	—	2026-06-16	2026-06-18
GERMAIN MARK Director · Ordinary Shares · 2026-06-16	Grant	120M	—	2026-06-16	2026-06-18

SEC filings

EDGAR filings in SCNI · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.